← Leaderboards
Jogesh Mukherjee
University Of Rochester
$14,647,605
Attributed
$18,314,390
Total exposure
15
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,314,390 · 15
By mechanism
R01$9,299,842 · 4
S10$2,899,840 · 3
RF1$2,206,425 · 1
R21$2,100,655 · 4
RC1$984,658 · 1
R33$659,334 · 1
Top collaborators
- Chin-Tu Chen6 shared
- William N. Green6 shared
- Bradley T Christian2 shared
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainImageBasePositron-Emission TomographyProgramsAffinityAlzheimer&AposKineticsRadiotracerRattusReceptorReportingRodentRadiometryParkinson DiseaseBrain RegionIn VivoFluorineBinding (Molecular Function)In VitroPharmaceutical PreparationsDiagnosisAgonistImaging Probe
Grant awards (42)
Novel Tau-Targeted Radiohalogenated Agents for Alzheimer's Disease$698,128
R01 · FY2025 · AG · contact PI
Novel Tau-Targeted Radiohalogenated Agents for Alzheimer's Disease$737,640
R01 · FY2024 · AG · contact PI
Evaluation of Monoamine Oxidase-A as a New Biomarker for Alzheimer's Disease$431,750
R21 · FY2022 · AG · contact PI
PET imaging of a4b2 nicotinic receptor upregulation and smoking cessation$681,004
R01 · FY2021 · DA
PET imaging of a4b2 nicotinic receptor upregulation and smoking cessation$691,354
R01 · FY2020 · DA
PET Imaging agents for a4b2 Nicotinic Receptors$249,088
RF1 · FY2020 · AG · contact PI
PET Imaging agents for a4b2 Nicotinic Receptors$1,957,337
RF1 · FY2019 · AG · contact PI
PET imaging of a4b2 nicotinic receptor upregulation and smoking cessation$701,775
R01 · FY2019 · DA
PET imaging of a4b2 nicotinic receptor upregulation and smoking cessation$705,943
R01 · FY2018 · DA
PET imaging of a4b2 nicotinic receptor upregulation and smoking cessation$332,368
R01 · FY2018 · DA
PET imaging of a4b2 nicotinic receptor upregulation and smoking cessation$732,915
R01 · FY2017 · DA
PET Imaging Agents for a4b2 Nicotinic Receptors$316,725
R01 · FY2017 · AG · contact PI
Fluorine-18 Labeled Functional Dopamine Receptor Imaging Agents$231,750
R21 · FY2017 · DA · contact PI
PET Imaging Agents for a4b2 Nicotinic Receptors$316,725
R01 · FY2016 · AG · contact PI
Fluorine-18 Labeled Functional Dopamine Receptor Imaging Agents$229,432
R21 · FY2016 · DA · contact PI
PET Imaging Agents for a4b2 Nicotinic Receptors$316,725
R01 · FY2015 · AG · contact PI
Fluorine-18 Labeled Functional Dopamine Receptor Imaging Agents$231,750
R21 · FY2015 · DA · contact PI
Cyclotron for PET Radiopharmaceuticals$1,968,840
S10 · FY2013 · OD · contact PI
PET Imaging Agents for a4b2 Nicotinic Receptors$298,498
R01 · FY2013 · AG · contact PI
18F-Mefway PET for Human Aging and Alzheimer's Disease$212,272
R33 · FY2013 · AG · contact PI
PET Imaging Agents for a4b2 Nicotinic Receptors$314,846
R01 · FY2012 · AG · contact PI
18F-Mefway PET for Human Aging and Alzheimer's Disease$223,895
R33 · FY2012 · AG · contact PI
Imaging Adrenergic Stimulation of Brown Adipose Tissue$191,250
R21 · FY2012 · DK · contact PI
PET Imaging Agents for a4b2 Nicotinic Receptors$313,820
R01 · FY2011 · AG · contact PI
Imaging Adrenergic Stimulation of Brown Adipose Tissue$229,500
R21 · FY2011 · DK · contact PI
18F-Mefway PET for Human Aging and Alzheimer's Disease$223,167
R33 · FY2011 · AG · contact PI
PET Imaging Agent for Diabetes Mellitus$499,937
RC1 · FY2010 · DK · contact PI
Dopamine D2/D3 Receptor Agonists for PET Imaging$338,099
R01 · FY2010 · EB · contact PI
PET Imaging Agent for Diabetes Mellitus$484,721
RC1 · FY2009 · DK · contact PI
Small Animal MicroCT$431,000
S10 · FY2009 · RR · contact PI
Dopamine D2/D3 Receptor Agonists for PET Imaging$341,513
R01 · FY2009 · EB · contact PI
PET Imaging Agents for Nicotinic a4b2 Receptors$245,098
R01 · FY2009 · AG · contact PI
18F-Mefway for Imaging Mood Disorders and Alzheimer's Disease$183,824
R21 · FY2009 · AG · contact PI
Dopamine D2/D3 Receptor Agonists for PET Imaging$36,830
R01 · FY2009 · EB · contact PI
Dopamine D2/D3 Receptor Agonists for PET Imaging$341,513
R01 · FY2008 · EB · contact PI
PET Imaging Agents for Nicotinic a4b2 Receptors$245,098
R01 · FY2008 · AG · contact PI
18F-Mefway for Imaging Mood Disorders and Alzheimer's Disease$183,824
R21 · FY2008 · AG · contact PI
Small Animal PET (microPET)$500,000
S10 · FY2007 · RR · contact PI
Dopamine D2/D3 Receptor Agonists for PET Imaging$343,125
R01 · FY2007 · EB · contact PI
PET Imaging Agents for Nicotinic a4b2 Receptors$250,100
R01 · FY2007 · AG · contact PI
18F-Mefway for Imaging Mood Disorders and Alzheimer's Disease$187,575
R21 · FY2007 · AG · contact PI
Design, construction and evaluation of PET imaging gene surrogate$163,636
U54 · FY2002 · NS